Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Inhaled treprostinil aims to slow lung decline in fibrosis trial

NCT ID NCT05943535

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 4 times

Summary

This phase 3 study tests whether an inhaled drug called treprostinil can slow the worsening of lung function in people with progressive pulmonary fibrosis, a condition where lung scarring gets worse over time. About 698 adults will receive either the drug or a placebo four times daily for 52 weeks. The main goal is to see if the drug helps maintain the amount of air they can exhale forcefully.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Inhaled treprostinil (Tyvaso)
What this could lead to
If it works, this could provide a new treatment to slow lung function decline and reduce hospitalizations in people with progressive pulmonary fibrosis.
What could go wrong
This is a phase 3 trial, but the drug may not prove effective or could cause side effects like cough or headache. Results may not apply to all forms of lung fibrosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 698 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subject gives voluntary informed consent to participate in the study. 2. Subject is ≥18 years of age, inclusive, at the time of signing informed consent. 3. Subject has radiological evidence of pulmonary fibrosis of \>10% extent on an HRCT scan in the previous 12 months (confirmed by central review). 4. Subject has a diagnosis of PPF (other than IPF) that fulfills at least 1 of the following criteria for progression within 24 months of screening despite standard treatment of ILD, as assessed by the Investigator: 1. Clinically significant decline in % predicted FVC based on ≥10% relative decline 2. Marginal decline in % predicted FVC based on ≥5% to \<10% relative decline combined with worsening of respiratory symptoms 3. Marginal decline in % predicted FVC based on ≥5% to \<10% relative decline combined with increasing extent of fibrotic changes on chest imaging 4. Worsening of respiratory symptoms as well as increasing extent of fibrotic changes on chest imaging 5. FVC ≥45% predicted at Screening (confirmed by central review). 6. Subjects must be on 1 of the following: 1. On nintedanib or pirfenidone for ≥90 days prior to Baseline and in the Investigator's opinion, are planning to continue treatment through the study 2. Not on treatment with nintedanib or pirfenidone for ≥90 days prior to Baseline and in the Investigator's opinion, not planning to initiate either treatment during the study. Concomitant use of both nintedanib and pirfenidone is not permitted. 7. Subjects treated with immunosuppressive agents (eg, mycophenolate, methotrexate, azathioprine, oral corticosteroids, rituximab) need to be on treatment for at least 120 days prior to Baseline and, in the Investigator's clinical opinion, must be refractory to treatment. 8. Women of childbearing potential must be non-pregnant (as confirmed by a urine pregnancy test at Screening and Baseline) and non-lactating, and will agree to do 1 of the following: 1. Abstain from intercourse (when it is in line with their preferred and usual lifestyle) 2. Use 2 medically acceptable, highly effective forms of contraception for the duration of the study, and at least 30 days after discontinuing study drug. i. Medically acceptable, highly effective forms of contraception can include approved hormonal contraceptives (oral, injectable, and implantable) and barrier methods (such as a condom or diaphragm) when used with a spermicide. Women who are successfully sterilized (including hysterectomy, bilateral salpingectomy, or bilateral oophorectomy) or postmenopausal (defined as amenorrhea for at least 12 consecutive months) are not considered to be of reproductive potential. 9. Males with a partner of childbearing potential must agree to use a condom for the duration of treatment and for at least 48 hours after discontinuing study drug. 10. In the opinion of the Investigator, the subject is able to communicate effectively with study personnel, and is considered reliable, willing, and likely to be cooperative with protocol requirements, including attending all study visits. Exclusion Criteria: 1. Subject is pregnant or lactating. 2. Subject has primary obstructive airway physiology (forced expiratory volume in 1 second/FVC \<0.70 at Screening) or greater extent of emphysema than fibrosis on HRCT (confirmed by central review). 3. Subject has a diagnosis of IPF. 4. Subject has shown intolerance or significant lack of efficacy to a prostacyclin or prostacyclin analogue that resulted in discontinuation or inability to effectively titrate that therapy. 5. Subject has received any PAH-approved therapy, including prostacyclin therapy (epoprostenol, treprostinil, iloprost, or beraprost; except for acute vasoreactivity testing), IP receptor agonists (selexipag), endothelin receptor antagonists, phosphodiesterase type 5 inhibitors (PDE5-Is), soluble guanylate cyclase stimulators, or activin signaling inhibitors (sotatercept) within 60 days prior to Baseline. As needed use of a PDE5-I for erectile dysfunction is permitted, provided no doses are taken within 48 hours prior to any study-related efficacy assessments. 6. Subject is receiving \>10 L/min of oxygen supplementation by any mode of delivery at rest at Baseline. 7. Exacerbation of ILD or active pulmonary or upper respiratory infection within 30 days prior to Baseline. Subjects must have completed any antibiotic or steroid regimens for treatment of the infection or acute exacerbation more than 30 days prior to Baseline to be eligible. If hospitalized for an acute exacerbation of ILD or a pulmonary or upper respiratory infection, subjects must have been discharged more than 90 days prior to Baseline to be eligible. 8. Subject has uncontrolled cardiac disease, defined as myocardial infarction within 6 months prior to Baseline or unstable angina within 30 days prior to Baseline. 9. Use of any other investigational drug/device or participation in any investigational study in which the subject received a medical intervention (ie, procedure, device, medication/supplement) within 30 days prior to Screening. Subjects participating in non-interventional, observational, or registry studies are eligible. 10. Acute pulmonary embolism within 90 days prior to Baseline. 11. In the opinion of the Investigator, the subject has any condition that would interfere with the interpretation of study assessments or would impair study participation or cooperation. 12. In the opinion of the Investigator, life expectancy \<12 months due to ILD or a concomitant illness. 13. Subject has received nerandomilast within 60 days prior to Baseline.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Interstitial lung disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    165 sites in 15 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • A & A Research Consultants, LLC

    RECRUITING

    McAllen, Texas, 78503, United States

  • AZORG

    RECRUITING

    Aalst, 9300, Belgium

  • Adventist Healthcare White Oak Medical Center

    RECRUITING

    Silver Spring, Maryland, 20904, United States

  • Aotearoa Clinical Trials Trust- Middlemore Hospital

    RECRUITING

    Auckland, New Zealand

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Ascension Medical Group St. Vincent's Lung Institute

    RECRUITING

    Jacksonville, Florida, 32204, United States

  • Assistance Publique Hôpitaux de Marseille - centre Hospitalier Régional de Marseille

    RECRUITING

    Marseille, France

  • Austin Health

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco" Presidio Ospedaliero Gaspare Rodolico

    RECRUITING

    Catania, 95123, Italy

  • Azienda Ospedaliero-Universitaria Senese

    RECRUITING

    Siena, 53100, Italy

  • Azienda Ospedaliero-Universitaria di Modena Policlinico di Modena

    RECRUITING

    Modena, 41124, Italy

  • Azienda Unita Sanitaria Locale Della Romagna Ospedale "Gian Battista Morgagni - Luigi Pierantoni" di Forlì

    RECRUITING

    Forlì, 47121, Italy

  • Banner University Medical Center Phoenix Lung Institute

    RECRUITING

    Phoenix, Arizona, 85006, United States

  • Barzilai Medical Center

    RECRUITING

    Ashkelon, 7830604, Israel

  • Baylor University Medical Center

    RECRUITING

    Dallas, Texas, 75246, United States

  • Beaumont Hospital, Royal Oak

    RECRUITING

    Royal Oak, Michigan, 48073, United States

  • Biocinetic Ltda.

    RECRUITING

    Santiago, Santiago Metropolitan, 8320000, Chile

  • Birmingham Heartlands Hospital

    RECRUITING

    Birmingham, United Kingdom

  • CEC Centro Estudios Clinicos

    RECRUITING

    Santiago, Santiago Metropolitan, 7550495, Chile

  • CHU Caen Normandie

    RECRUITING

    Caen, 14000, France

  • CHU de Liège

    RECRUITING

    Liège, 4000, Belgium

  • CIC Mauricie inc.

    RECRUITING

    Québec, Quebec, G8T 7A1, Canada

  • CIMER-Centro Integral de Medicina Respiratoria

    RECRUITING

    San Miguel de Tucumán, Tucumán Province, Argentina

  • CINME Centro de Investigaciones Metabolicas

    RECRUITING

    Buenos Aires, C1056ABI, Argentina

  • CUB Hopital Erasmde

    RECRUITING

    Brussels, 1070, Belgium

  • Canterbury Respiratory Research Group

    RECRUITING

    Christchurch, Canterbury, 8011, New Zealand

  • Centre Hospitalier Régional Universitaire de Tours

    RECRUITING

    Tours, Tours Cedex 9, France

  • Centro Respiratorio Integral LTDA. (CENRESIN)

    RECRUITING

    Quillota, Valparaiso, 2260000, Chile

  • Centro Ricerche Cliniche di Verona SrL Pneumology Unit

    RECRUITING

    Verona, 37134, Italy

  • Centro de Investigacion Curico

    RECRUITING

    Curicó, Maule Region, 3341643, Chile

  • Centro de Investigacion de Enfermedades Respiratorias - Clinica Providencia

    RECRUITING

    Lima, 15088, Peru

  • Centro de Investigación de Enfermedades Respiratorias e Inmunológicas (CIERI)

    RECRUITING

    Viña del Mar, Valparaiso, 2520000, Chile

  • Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital

    RECRUITING

    Kaohsiung City, 83301, Taiwan

  • Christopher King, MD

    RECRUITING

    Falls Church, Virginia, 22042, United States

  • Cleveland Clinic Florida

    RECRUITING

    Weston, Florida, 33331, United States

  • Clinica Internacional - Sede Lima

    RECRUITING

    Lima, 15001, Peru

  • Clinica Ricardo Palma

    RECRUITING

    Lima, 15036, Peru

  • Clinical Trials Center of Middle Tennessee, LLC

    RECRUITING

    Franklin, Tennessee, 37067, United States

  • Cliniques Universitaires St.-Luc

    RECRUITING

    Brussels, 1200, Belgium

  • Corewell Health Grand Rapids Hospitals - Butterworth

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Diex Recherche Inc. - Division Sherbrooke Est

    RECRUITING

    Sherbrooke, Quebec, J1E 0N8, Canada

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Dynamic Drug Advancement Limited

    RECRUITING

    Ajax, Ontario, L1S 2J5, Canada

  • East Carolina University

    RECRUITING

    Greenville, North Carolina, 27834, United States

  • Eastern Health Box Hill Hospital

    RECRUITING

    Box Hill, Victoria, 3128, Australia

  • Fondazione IRCCS San Gerardo dei Tintori

    RECRUITING

    Monza, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, 168, Italy

  • Fundacion Medica San Cristobal

    RECRUITING

    Santiago, Santiago Metropolitan, 7630226, Chile

  • Fundación Respirar

    RECRUITING

    Buenos Aires, C1426ABP, Argentina

  • Gachon University Gil Medical Center

    RECRUITING

    Incheon, 21565, South Korea

  • Georgetown University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

  • Guy's Hospital

    RECRUITING

    London, SE1 9RT, United Kingdom

  • Hillel Yaffe Medical Center

    RECRUITING

    Hadera, 3846201, Israel

  • Hospices civils de Lyon - Hôpital Louis Pradel

    RECRUITING

    Bron, 69500, France

  • Hospital Central de la Fuerza Aerea del Peru

    RECRUITING

    Lima, 15046, Peru

  • Hospital Nacional Adolfo Guevara Velasco

    RECRUITING

    Cusco, 08002, Peru

  • Hospital of the University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Houston Methodist Outpatient Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Hôpital Avicennes

    RECRUITING

    Bobigny, 93000, France

  • Hôpital Maisonneuve-Rosemont

    RECRUITING

    Montreal, Quebec, H1T 2M4, Canada

  • Infinity Medical Center

    RECRUITING

    North Dartmouth, Massachusetts, 02747, United States

  • Institute for Respiratory Health

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

  • Institute for Respiratory Health - Midland

    RECRUITING

    Midland, Western Australia, 6056, Australia

  • Instituto Ave Pulmo - Fundacion enfisema

    RECRUITING

    Mar del Plata, Buenos Aires, 7600, Argentina

  • Instituto Medico Rio Cuarto

    RECRUITING

    Río Cuarto, Córdoba Province, 5800, Argentina

  • Instituto de Medicina Respiratoria

    RECRUITING

    Córdoba, 5003, Argentina

  • Intermountain Medical Center

    RECRUITING

    Murray, Utah, 84107, United States

  • Investigaciones en Patologias Respiratorias

    RECRUITING

    San Miguel de Tucumán, Tucumán Province, 4000, Argentina

  • Jefferson Honickman Center

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Johns Hopkins Asthma and Allergy Center

    RECRUITING

    Baltimore, Maryland, 21224, United States

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    RECRUITING

    Kaohsiung City, 807, Taiwan

  • Kaplan Medical Center

    RECRUITING

    Rehovot, 7551041, Israel

  • Korea University Anam Hospital

    RECRUITING

    Seoul, 02841, South Korea

  • LMU Klinikum Medizinische Klinik und Poliklinik V

    RECRUITING

    München, 81377, Germany

  • Loyola University Medical Center

    RECRUITING

    Maywood, Illinois, 60153, United States

  • Lung Research QLD

    RECRUITING

    Chermside, Queensland, 4032, Australia

  • Lungenfachklinik Immenhausen

    RECRUITING

    Immenhausen, 34376, Germany

  • Manchester University NHS Foundation Trust, North Manchester General Hospital

    RECRUITING

    Manchester, M8 5RB, United Kingdom

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226-1222, United States

  • Medical University of South Carolina-Nexus

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, Lower Saxony, 30625, Germany

  • Meir Medical Center

    RECRUITING

    Kfar Saba, 4428164, Israel

  • Memorial Hospital at Gulfport

    RECRUITING

    Gulfport, Mississippi, 39501, United States

  • Mercy Health St.Vincent Medical Center LLC

    RECRUITING

    Toledo, Ohio, 43608, United States

  • Methodist Hospital

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Metroplex Pulmonary and Sleep Center

    RECRUITING

    McKinney, Texas, 75069, United States

  • Monash Health-Monash Medical Centre

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10467, United States

  • NHS Lothian, Royal INfirmary of Edingburgh

    RECRUITING

    Edinburgh, EH16 4SA, United Kingdom

  • NHS Tayside, Perth Royal Infirmary

    RECRUITING

    Perth, PH1 1NX, United Kingdom

  • NewportNativeMD, Inc.

    RECRUITING

    Newport Beach, California, 92663, United States

  • Northwell Health

    RECRUITING

    New Hyde Park, New York, 11042, United States

  • Northwestern Memorial Hospital, Clinical Research Unit

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Norton Thoracic Institute

    RECRUITING

    Phoenix, Arizona, 85013, United States

  • Paradigm Clinical Research

    RECRUITING

    Redding, California, 45227, United States

  • Paradigm Clinical Research

    RECRUITING

    San Diego, California, 92108, United States

  • Pennsylvania State Hershey Medical Center and College of Medicine

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Peter Morton Medical Building

    RECRUITING

    Los Angeles, California, 90095, United States

  • Prisma Health Pulmonology-Richland

    RECRUITING

    Columbia, South Carolina, 29203, United States

  • Prufstelle der GWT am Fachkrankenhaus Coswig

    RECRUITING

    Coswig, 01640, Germany

  • PulmonIx LLC

    RECRUITING

    Greensboro, North Carolina, 27403, United States

  • Pulmonary Associates of Richmond, Inc.

    RECRUITING

    Richmond, Virginia, 23230, United States

  • Rabin Medical Center

    RECRUITING

    Haifa, 3436212, Israel

  • Rabin Medical Center

    RECRUITING

    Petah Tikva, 4941492, Israel

  • RoMed Klinikum Rosenheim-Ellmaierstr. 23

    RECRUITING

    Rosenheim, Bavaria, 83022, Germany

  • Rouen University Hospital

    RECRUITING

    Rouen, 7600, France

  • Royal Papworth Hospital

    RECRUITING

    Cambridge, CB2 0AY, United Kingdom

  • Royal Prince Alfred Hospital

    RECRUITING

    Camperdown, New South Wales, 2050, Australia

  • Royal University Hospital

    RECRUITING

    Saskatoon, Saskatchewan, S7N 0W8, Canada

  • Rush University Medical Center Outpatient Pulmonary Clinic

    RECRUITING

    Chicago, Illinois, 60612, United States

  • SLK Kliniken Heilbronn GmbH

    RECRUITING

    Löwenstein, 74245, Germany

  • Saint Luke's Hospital of Kansas City

    RECRUITING

    Kansas City, Missouri, 64111, United States

  • Sanatorio Allende Cerro

    RECRUITING

    Córdoba, 5021, Argentina

  • Sanatorio Parque de Rosario - Consultorios Externos

    RECRUITING

    Rosario, Santa Fe Province, 2000, Argentina

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, 13620, South Korea

  • Shaare Zedek Medical Center

    RECRUITING

    Jerusalem, 9103102, Israel

  • St George Hospital

    RECRUITING

    Kogarah, New South Wales, 2217, Australia

  • St. Luke's Univeristy Health Network-Pulmonary & Critical Care

    RECRUITING

    Cincinnati, Ohio, 45227, United States

  • St.Joseph's Healthcare Hamilton

    RECRUITING

    Hamilton, Ontario, L8N 4A6, Canada

  • St.Paul's Hospital

    RECRUITING

    Vancouver, British Columbia, V6Z 176, Canada

  • Stanford University Medical Center

    RECRUITING

    Stanford, California, 94305, United States

  • StatCare Pulmonary Consultants, PLLC

    RECRUITING

    Knoxville, Tennessee, 37919, United States

  • Stony Brook Advanced Specialty Care

    RECRUITING

    Stony Brook, New York, 11794-8172, United States

  • TGH/USF Center for Advanced Lung Disease and Lung Transplant

    RECRUITING

    Tampa, Florida, 33606, United States

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, 40705, Taiwan

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Temple University Hospital

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    RECRUITING

    Seoul, 3312, South Korea

  • The Emory Clinic

    RECRUITING

    Atlanta, Georgia, 45227, United States

  • The Hadassah University Medical Center Ein Kerem Hospital

    RECRUITING

    Jerusalem, 9112001, Israel

  • The Lung Research Center, LLC

    RECRUITING

    Chesterfield, Missouri, 63017, United States

  • The Ohio State University Wexner Medical CEnter

    RECRUITING

    Columbus, Ohio, 43201, United States

  • The Prince Charles Hospital

    RECRUITING

    Brisbane, Queensland, Australia, Australia

  • The University of Texas Health Science Center at Houston, McGovern Medical School

    RECRUITING

    Houston, Texas, 77030, United States

  • The Vanderbilt Lung Institute

    RECRUITING

    Nashville, Tennessee, 37204, United States

  • Tufts Medical Center

    RECRUITING

    Boston, Massachusetts, 02111, United States

  • Tulane Medical Center

    RECRUITING

    New Orleans, Louisiana, 45227, United States

  • UAB Lung Health Center

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • UC Davis Health Medical Center

    RECRUITING

    Sacramento, California, 95817, United States

  • UI Health Hospital

    RECRUITING

    Chicago, Illinois, 60612, United States

  • UT Southwestern Medical Center-Advanced Lung Clinic

    RECRUITING

    Dallas, Texas, 75390, United States

  • UZ Leuven

    RECRUITING

    Leuven, 3000, Belgium

  • Unidad de Investigacion de Enfermedades Respiratorias- Clinica San Pablo -Surco

    RECRUITING

    Lima, 15023, Peru

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University Hospital and UW Health Clinics

    RECRUITING

    Madison, Wisconsin, 53792, United States

  • University of California Irvine Medical Center

    RECRUITING

    Orange, California, 92868, United States

  • University of Cincinnati Medical Center

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Kentucky

    RECRUITING

    Lexington, Kentucky, 45227, United States

  • University of Louisville Healthcare Outpatient Research Clinic

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of Maryland Medical Center

    RECRUITING

    Baltimore, Maryland, 45227, United States

  • University of Minnesota Health Clinical Research Unit (CRU)

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • University of New Mexico

    RECRUITING

    Albuquerque, New Mexico, 87131, United States

  • University of Utah Health

    RECRUITING

    Salt Lake City, Utah, 84108, United States

  • University of Virginia Health System

    RECRUITING

    Charlottesville, Virginia, 22903, United States

  • Waikato Hospital

    RECRUITING

    Hamilton, 3204, New Zealand

  • Wake Forest Baptist Health

    RECRUITING

    Winston-Salem, North Carolina, 27104, United States

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Weill Cornell Medicine, New York-Presbyterian Hospital

    RECRUITING

    New York, New York, 10065, United States

  • ZAS Middelheim

    RECRUITING

    Antwerp, 2020, Belgium

  • Zentralklinik Bad Berka GmbH Klinik für Pneumologie, Zentrum für Schlaf-und Beatmungsmedizin

    RECRUITING

    Bad Berka, 99437, Germany

  • uhrlandklinik Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

    RECRUITING

    Essen, 45239, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.